Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages-Reference-Cited by-同舟云学术

Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages

Published:2023-04-07 Issue:3 Volume:41 Page:467-473
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Whitley Heather P.¹²^ORCID,Trujillo Jennifer M.³,Neumiller Joshua J.⁴^ORCID

Affiliation:

1. 1Department of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Auburn, AL

2. 2Clinical Pharmacy Specialist, Baptist Family Medicine, Baptist Health System, Montgomery, AL

3. 3Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO

4. 4Department of Pharmacotherapy, Washington State University, Spokane, WA

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/41/3/467/729085/diaclincd230023.pdf

Reference38 articles.

1. Putka S . Diabetes patients also struggle to access GLP-1 agonists: patients are making substitutions, crossing state lines, stopping care because of shortages. Available from https://www.medpagetoday.com/special-reports/features/102773#:∼:text=All%20three%20of%20the%20most,loss%20and%20is%20expected%20to. Accessed 10 March 2023

2. U.S. Food and Drug Administration . FDA drug shortages. Available from https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm. Accessed 10 March 2023

3. PCDS consensus statement: a strategy for managing the supply shortage of the GLP-1 RAs Ozempic and Trulicity;Beba;Diabetes & Primary Care,2022

4. The role of outsourcing facilities in overcoming drug shortages;Mattingly;J Am Pharm Assoc (2003),2021

5. Landsverk G . Shortages of a ‘game changer’ weight-loss drug are driving people to buy potentially risky knockoff versions. Available from https://www.insider.com/buy-compounded-semaglutide-online-risks-wegovy-ozempic-2023-1. Accessed 10 March 2023

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1 agonists: A review for emergency clinicians;The American Journal of Emergency Medicine;2024-04

2. Use of Dulaglutide, Semaglutide, and Tirzepatide in Diabetes and Weight Management;Clinical Therapeutics;2024-02

3. Monitoring Report: GLP-1 RA Prescribing Trends - December 2023 Data;2024-01-22

4. Navigating Uncharted Waters: Long-Term Implications of GLP-1 Agonist Use;Surgery for Obesity and Related Diseases;2024-01

5. Verapamil chronicles: advances from cardiovascular to pancreatic β-cell protection;Frontiers in Pharmacology;2023-11-27